- In june 2024, abbott laboratories expanded its footprint in africa by partnering with the nigerian ministry of health to deploy its m-pima™ hiv-1/2 vl platform across remote regions for rapid hiv viral load testing. this initiative aims to enhance access to decentralized diagnostics and strengthen national efforts in hiv monitoring and treatment, aligning with global 95-95-95 targets for hiv control
- in may 2024, roche diagnostics launched a mobile diagnostic initiative in kenya in collaboration with the clinton health access initiative (chai), introducing portable molecular testing platforms in underserved counties. this move is part of roche’s broader strategy to support disease surveillance and improve early diagnosis of tuberculosis and hepatitis in low-resource environments
- in april 2024, south africa's national health laboratory service (nhls) integrated cepheid’s genexpert® systems into its mobile health units as part of a national strategy to combat tuberculosis and drug-resistant infections. the deployment focuses on enabling rapid molecular testing in rural provinces, enhancing detection accuracy and reducing diagnostic delays
- in march 2024, sd biosensor and the uae’s ministry of health and prevention entered a strategic agreement to provide point-of-care covid-19 and flu testing devices across airports, schools, and community health centers. the agreement reinforces the uae's commitment to resilient healthcare infrastructure and pandemic preparedness
- in january 2024, siemens healthineers partnered with the egyptian ministry of health to introduce clinitest® rapid covid-19 antigen tests as part of a broader point-of-care diagnostics campaign. targeted at high-traffic areas such as transport hubs and government offices, the initiative supports egypt’s efforts in ensuring accessible and fast testing solutions during peak seasonal outbreaks
